CAMP Q2 2019 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$89M-6.1% YoY

Gross Profit

$35M39.8% margin

Operating Income

-$7M-7.5% margin

Net Income

-$9M-9.8% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+5.6%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$652M

Total Liabilities

$453M

Stockholders' Equity

$199M

Cash & Equivalents

$190M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$95M	-6.1%
Gross Profit	$35M	$38M	-7.0%
Operating Income	-$7M	-$574,000	-1057.8%
Net Income	-$9M	$9M	-202.1%

Revenue Segments

Product

$64M71%

Application Subscriptions And Related Products And Service

$26M29%

Geographic Segments

UNITED STATES

$63M71%

E M E A

$13M15%

All Other

$4M4%

Latin America

$3M4%

CANADA

$3M3%

Asia Pacific

$2M3%